• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,927.61 57.71
(0.11%)
Dow Jones
7,374.18 -5.04
(-0.07%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,536.79 75.16
(0.72%)
Forex
USD-INR
94.55 -0.19
(-0.20%)
EUR-INR
107.36 -0.64
(-0.59%)
GBP-INR
124.56 -0.65
(-0.52%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
21.8
15164.85
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.56
 

avantel ltd
Infosys gains as GlobalFoundries expands AI-led IT services partnership
Jun 24,2026
Under the agreement, Infosys will deliver AI-led managed services across GlobalFoundries' enterprise IT landscape. The engagement covers end-to-end management of application, infrastructure, data and service desk operations.

GlobalFoundries selected Infosys based on its existing relationship as a technology provider and the latter's semiconductor industry expertise. The collaboration aims to transform the company's IT operations through a managed services model powered by artificial intelligence, automation and continuous optimization.

The partnership is expected to help GlobalFoundries improve operational efficiency, strengthen resilience and enhance user experience as part of its ongoing digital transformation initiatives.

Infosys said it will leverage its AI capabilities, domain expertise and outcome-based operating model to help reduce IT incidents, improve end-user experiences and lower total cost of ownership over the long term. The company added that the engagement will support GlobalFoundries' transition from reactive IT management to predictive and autonomous service delivery.

Infosys is a global leader in business consulting and technology services. The company reported a 27.75% increase in consolidated net profit to Rs 8,501 crore on a 2.02% rise in revenue from operations to Rs 46,402 crore in Q4 FY26 over Q3 FY26.